These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 2489657)

  • 1. [Hepatitis B virus and epidemiological study on efficacy of HBIG and vaccine for the prevention of type B hepatitis after accidental exposures among medical staffs (2)].
    Kimura T; Iwamiya M; Yoshida N; Iwamoto A; Sasada M; Ito S; Kikuchi N; Yagi S; Higaki M
    Kanagawa Shigaku; 1989 Sep; 24(2):393-8. PubMed ID: 2489657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
    Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
    Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
    Lo KJ; Tsai YT; Lee SD; Yeh CL; Wang JY; Chiang BN; Wu TC; Yeh PS; Goudeau A; Coursaget P
    Hepatogastroenterology; 1985 Apr; 32(2):65-8. PubMed ID: 3159639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection].
    Xia GL; Gong J; Wang JJ; Meng ZD; Jia ZY; Cao HL; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):362-5. PubMed ID: 12820927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation.
    Takaki A; Yagi T; Iwasaki Y; Sadamori H; Matsukawa H; Matsuda H; Shinoura S; Umeda Y; Miyake Y; Terada R; Kobashi H; Sakaguchi K; Tanaka N; Shiratori Y
    Transplantation; 2007 Jan; 83(2):231-3. PubMed ID: 17264822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen.
    Schalm SW; Mazel JA; de Gast GC; Heijtink RA; Botman MJ; Bänffer JR; Cerards LJ; Zwijnenberg J; Fetter WP; Nuijten SM
    Pediatrics; 1989 Jun; 83(6):1041-8. PubMed ID: 2726331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.
    Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH
    Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Course of antibody titer following preventive hepatitis B vaccination and a recommendation for renewal following the use of H-B-Vax vaccines].
    Kätzner K; Kalitzky M; Steinhagen-Thiessen E; Gatermann S; Laufs R
    Z Gastroenterol; 1985 Jan; 23(1):18-24. PubMed ID: 2932862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W; Muszyńska M; Pawłowska M
    Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
    Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of vertical transmission of HBV by administration of hepatitis B vaccine combined with HBIG and long-term follow-up of HBsAb titer.
    Monna T; Kuroki T; Oka H; Yamamoto S; Murata R; Suyama I; Issiki G; Nakao M
    Osaka City Med J; 1988 Jul; 34(1):9-17. PubMed ID: 3419810
    [No Abstract]   [Full Text] [Related]  

  • 16. HBIG efficacy in preventing HBV infection in infants.
    D'Elia R; Pornaro E; Gussetti N; Largajolli G
    Dev Biol Stand; 1983; 54():377-81. PubMed ID: 6653892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
    Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
    Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation.
    Adler R; Safadi R; Caraco Y; Rowe M; Etzioni A; Ashur Y; Shouval D
    Hepatology; 1999 Apr; 29(4):1299-305. PubMed ID: 10094978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.